Armistice Capital’s Creative Medical Technology CELZ Stock Holding History
Bought
Maintained
Sold
Other funds holding CELZ
Armistice Capital's CELZ Position: Q3 2026 in Review
Armistice Capital sold out of Creative Medical Technology (CELZ) in Q3 2026, closing a stake of 42,000 shares — an estimated $60.9K sold.
Armistice Capital first reported a position in CELZ in Q2 2022 and held it in 3 quarters. The position peaked at $933K in Q2 2022. 16 funds tracked by Wall St. Rank hold CELZ as of Q3 2026.
- Armistice Capital reported no remaining Creative Medical Technology position as of Q3 2026 after selling out during the quarter.
- Armistice Capital sold 42,000 Creative Medical Technology shares in Q3 2026, an estimated $60.9K.
- Armistice Capital first reported a position in Creative Medical Technology in Q2 2022 and held it in 3 quarters.
- Armistice Capital's Creative Medical Technology position peaked at $933K in Q2 2022.
- 16 funds tracked by Wall St. Rank held Creative Medical Technology as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.